In summary, we applied silico prediction to study the material basis and mechanism of YQG against lung cancer, and confirmed that luteolin can inhibit the proliferation and migration of lung cancer cells in vitro validation, and the mechanism of luteolin's action on lung cancer cells may be related to its docking at the phosphorylation site of THR 877 of the AR protein. Here, AR is linked to lung carcinoma.